| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 73 |
| 1 | TADALAFIL | 44 |
| 2 | SILDENAFIL CITRATE | 41 |
| 3 | AMBRISENTAN | 38 |
| 4 | MACITENTAN | 38 |
| 5 | SILDENAFIL | 24 |
| 6 | SODIUM CHLORIDE | 24 |
| 7 | EPOPROSTENOL | 23 |
| 8 | SODIUM CHLORIDE TABLET | 23 |
| 9 | SODIUM CHLORIDE TABLETS | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CENTRUROIDES (SCORPION) IMMUNE F(AB)2 (EQUINE) | 1 | 0.0526 |
| 1 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 2 | FLOXURIDINE | 1 | 0.0058 |
| 3 | DIMETICONE | 1 | 0.0035 |
| 4 | CASIMERSEN | 3 | 0.0030 |
| 5 | SMOFLIPID | 2 | 0.0023 |
| 6 | PLATINUM | 1 | 0.0019 |
| 7 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 2 | 0.0018 |
| 8 | EPOPROSTENOL | 23 | 0.0018 |
| 9 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antivenin [EPC] | 1 | 0.0526 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 16 | 0.0012 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 4 | Prostacycline Vasodilator [EPC] | 95 | 0.0007 |
| 5 | Antisense Oligonucleotide [EPC] | 7 | 0.0006 |
| 6 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 7 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 8 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 16 | 0.0005 |